BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38106845)

  • 1. Ovarian Hyperthecosis in a 12-year-old Chinese Girl Presenting With Virilization.
    Lai TS; Wong EW; Hui HF; Wong LM
    JCEM Case Rep; 2024 Jan; 2(1):luad140. PubMed ID: 38106845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot Pure GnRH Antagonist for Long-term Treatment of Ovarian Hyperthecosis Monitored by Multisteroid LCMS Profiling.
    Ni H; Schmidli R; Savkovic S; Strasser SI; Hetherington J; Desai R; Handelsman DJ
    J Endocr Soc; 2021 Dec; 5(12):bvab167. PubMed ID: 34877444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the Virilizing Girl at Puberty.
    Santi M; Graf S; Zeino M; Cools M; Van De Vijver K; Trippel M; Aliu N; Flück CE
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1530-1539. PubMed ID: 33367768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
    Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
    J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virilization due to ovarian hyperthecosis in a postmenopausal woman.
    van Heyningen C; MacFarlane IA; Diver MJ; Muronda C; Tuffnell D
    Gynecol Endocrinol; 1988 Dec; 2(4):331-8. PubMed ID: 3232554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian hyperthecosis in the setting of portal hypertension.
    Speiser PW; Susin M; Sasano H; Bohrer S; Markowitz J
    J Clin Endocrinol Metab; 2000 Feb; 85(2):873-7. PubMed ID: 10690904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels.
    Shah S; Torres C; Gharaibeh N
    Case Rep Endocrinol; 2022; 2022():9998807. PubMed ID: 35087692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
    Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
    AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Ovarian Hyperthecosis in a Postmenopausal Woman.
    Yousaf S; Nizar R; John L; Simpson A
    JCEM Case Rep; 2023 Nov; 1(6):luad148. PubMed ID: 38077307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
    Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
    Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
    Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
    Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Ovarian Vein Sampling to Lateralize a Virilizing Leydig Cell Ovarian Tumor.
    Baweja K; Shuster S; Awad S
    AACE Clin Case Rep; 2023; 9(6):182-185. PubMed ID: 38045790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hyperandrogenism due to ovarian hyperthecosis in a young woman.
    Goyal A; Malhotra R; Kulshrestha V; Kachhawa G
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31852694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.